医学
持续气道正压
指南
临床实习
工作队
气道正压
重症监护医学
物理疗法
血压
心房颤动
呼吸
阻塞性睡眠呼吸暂停
正压
睡眠(系统调用)
循证医学
安眠药
睡眠呼吸障碍
气道
系统回顾
梅德林
临床试验
睡眠呼吸暂停
心脏病学
任务(项目管理)
循证实践
随机对照试验
临床研究
内科学
作者
Dries Testelmans,Esther Irene Schwarz,Ulla Anttalainen,Özen K. Başoğlu,Matteo Bradicich,Sonja Craig,Marta Drummond,Alberto Giannoni,Raphael C. Heinzer,Hennie Janssen,Valérie Labonté,Mirjam Elisa Ljunggren,Miguel Ángel Martínez‐García,Stefan D. Mihaicuta,Gabriel Natan Pires,Gianfranco Parati,Jean Louis Pepin,Luca Roberti,Silke Ryan,Andreja Šajnić
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2026-10-11
卷期号:: 2601186-2601186
标识
DOI:10.1183/13993003.01186-2026
摘要
BACKGROUND: Continuous positive airway pressure (CPAP) is the primary treatment for obstructive sleep apnoea (OSA), although its effectiveness may vary across OSA subtypes. This joint European Respiratory Society (ERS)/European Sleep Research Society (ESRS) clinical practice guideline evaluates CPAP's impact on patient-centred and prognostically relevant outcomes, comparing it to no or sham treatment in different OSA subgroups. METHODS: The joint ERS/ESRS Task Force consisted of experts in pulmonology, cardiology and respiratory sleep medicine, patient representatives and methodologists. Questions were formulated using the PICO (Population, Intervention, Comparator, Outcomes) framework. A systematic review assessing the effects of CPAP on critical outcomes was performed. The certainty of evidence for all outcomes was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Consensus on the direction and strength of the recommendation was informed by Evidence-to-Decision frameworks and achieved through discussions and voting. RECOMMENDATIONS: The Task Force generally suggests CPAP treatment for OSA because of its beneficial effects on sleepiness, other patient-reported outcomes and blood pressure (conditional recommendations). CPAP is recommended in patients with excessive daytime sleepiness (EDS) (strong recommendation). Additional specific conditional recommendations are given for patients with moderate-to severe OSA, the elderly, and patients with arterial and treatment-resistant hypertension. The Task Force suggests either CPAP or no treatment in patients without EDS (but taking into account other OSA-related symptoms), in patients with atrial fibrillation with the aim of reducing its recurrence and in patients with impaired glucose metabolism to improve glycaemic control. CONCLUSION: CPAP is an effective treatment for adults with OSA. However, recommendations for its use vary across different patient subgroups.
科研通智能强力驱动
Strongly Powered by AbleSci AI